Peptides, Drugs And Supplements: Science, Risks, And Alternatives Los Angeles Times FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn